Last updated on July 2019

Ovarian Autologous-Platelet Rich Plasma Treatment (PRP) in Menopause.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Anovulatory Infertility | Menopause | Amenorrhea | Female infertility
  • Age: Between 45 - 55 Years
  • Gender: Female

Inclusion Criteria:

  • Amenorrhea at least for 12 months
  • Stopped HRT for at least 3 months
  • Stopped Botanotherapy / Danazol for 3 months
  • Willing to comply with study requirements

Exclusion Criteria:

  • Current diagnosis of cancer
  • Ovarian inaccessibility
  • Current or previous premature ovarian failure
  • Endocrinologic disorders (Thyroid Dysfunction, Diabetes mellitus, Metabolic syndrome),
  • BMI>30 kg/m2
  • Systematic autoimmune disorders

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.